PerkinElmer Launches ChemDraw® V21 Software, Empowering Researchers to Rapidly Create Chemically Intelligent Microsoft PowerPoint Reports

Ability to import 3D molecular models with one click accelerates information sharing, collaboration and decision making WALTHAM, Mass. – March 2, 2022 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced V21 of its ChemDraw® software featuring the ability to import, animate and share 3D chemical structures natively in... Read more

PerkinElmer to Present at Upcoming Investor Conferences

WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 1, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen 42nd Annual Health Care Conference and the Barclays Global Healthcare Conference. Cowen 42nd Annual Health Care Conference – Virtual Monday, March 7, 202210:30 a.m. ET –... Read more

Bruker Releases CCS-Enabled TIMScore™ and TIMS DIA-NN 4D Proteomics Software

Bruker PaSER™ 2022 software now features TIMS DIA-NN processing for dia-PASEF® Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies ~9000 protein groups from 200 ng K562 lysate in just 35 min gradient TIMScore further increases phosphopeptides detection by ~25% CHARLESTON, S.C.–(BUSINESS WIRE)– At US HUPO,Bruker Corporation (Nasdaq: BRKR) announced its TIMS... Read more

TetraScience Announces Collaboration with PerkinElmer to Provide Signals Research™ Suite Customers with Accelerated Time to Value and Improved Scientific Data Outcomes

Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more

Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration

Agreement to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies CAMBRIDGE, Mass., & WALTHAM, Mass.–(BUSINESS WIRE)– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement... Read more

Bruker Announces Quarterly Dividend

Q1 2022 dividend increases to $0.05 from $0.04 per share in Q1 2021 BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 18,... Read more

PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy

Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its SIRION Biotech business, a world leader in viral vector-based gene delivery technologies for gene and cell therapy and vaccine development, and the Centre for Genomic Regulation (CRG), an international... Read more